HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Teaching physicians how to talk
-
- Doctors in Japan call for collection of PBSCs from Fukushima workers
- FDA approves non-invasive therapy for glioblastoma
- ODAC approves everolimus for treatment of pancreatic neuroendocrine tumors
- ODAC approves indication for sunitinib in treatment of PNET
- A 68-year-old woman with lung cancer and late-onset bipolar disorder Jeremy Matuszak, MD; Johanna W. DeKay, MD
- Purine analogs provide first-line defense against HCL Munir Ghesani, MD, FACNM; Irene Dy, MD; Gabriel Sara, MD; Rosna Mirtcheva, MD
- Accelerated approval for oncology drugs successful, but improvements needed
- Hormone therapy reduced risk for breast cancer after hysterectomy
-
- Patient self-monitoring linked to fewer deaths, thromboembolic events in anticoagulation with vitamin K antagonists
- Prior surgery, lesion location may be linked to higher-grade meningiomas
- Researchers complete sequencing of multiple myeloma genome
- Small proportion of excess second solid cancers attributed to radiotherapy
- Smoking cessation after liver transplant reduced incidence of transplant-related carcinoma
- Survey: Physicians recommend different treatments than those they choose for themselves
- Temozolomide plus bevacizumab well-tolerated in hemangiopericytomas and malignant solitary fibrous tumors
- Assessing promoter methylation patterns in breast milk may shed light on breast cancer risk
-
- Genomic analysis may lead to targeted breast cancer therapies
- Hypertension drug may improve endobronchial dysplasia in former smokers
- Serum biomarkers may identify lung cancer in never smokers
- Solid tumors may benefit from new drug combination
- Health model targets individualized care for pediatric oncology patients Christine A. Zawistowski, MD